A Population Pharmacokinetic Approach to Describe Cephalexin Disposition in Adult and Aged Dogs

Abstract EN

This study was conducted in order to characterize the pharmacokinetics of orally administered cephalexin to healthy adult and aged dogs, using a population pharmacokinetic approach.

Two hundred and eighty-six cephalexin plasma concentrations obtained from previous pharmacokinetic studies were used.

Sex, age, pharmaceutical formulation, and breed were evaluated as covariates.

A one-compartment model with an absorption lag-time (Tlag) best described the data.

The final model included age (adult; aged) on apparent volume of distribution (Vd/F), apparent elimination rate (ke/F), and Tlag; sex (female; male) on ke/F, and breed (Beagle; mixed-breed) on Vd/F.

Addition of the covariates to the model explained 78% of the interindividal variability (IIV) in Vd/F, 36% in ke/F, and 24% in Tlag, respectively.

Formulation did not affect the variability of any of the pharmacokinetic parameters.

Tlag was longer, whereas Vd/F and ke/F were lower in aged compared to adult animals; in female aged dogs ke/F was lower than in male aged dogs; however, the differences were of low magnitude.

Different disposition of cephalexin may be expected in aged dogs.